Term
Passing through the physical barrier |
|
Definition
-Wound -Injection (insect bite) -Attachment to and colonization of the host surfaces -Invasion of host cells |
|
|
Term
|
Definition
Pass through
Avoid the innate immune defenses at the host interface |
|
|
Term
Types of Physical Barriers |
|
Definition
|
|
Term
Mucosal Surfaces Defenses |
|
Definition
Enzymes (Lysozymes)
Antimicrobial peptides (Defensins)
Immunoglobulines (IgA) |
|
|
Term
|
Definition
Lysozymes are a family of enzymes that damage bacterial cell walls by catalyzing the hydrolysis of the peptidoglycan.
tLysozyme is the most abundant |
|
|
Term
|
Definition
Defensins have been considered as ‘natural peptide antibiotics’ to combat infections.
Defensins are toxic for microorganisms and combat viral infections. |
|
|
Term
|
Definition
Neutralize toxins, viruses, limit attachment of pathogens to the host surfaces. Effector functions such as initiation of phagocytosis. |
|
|
Term
Inhibitors that Prevent Lysozyme Activity |
|
Definition
SIC (Streptococcal Inhibitor of Complement) : 31 kDa protein secreted by a few highly virulent strains of Streptococci. Binds to, and inhibit lysozymes.
MliC (Membrane-bound Lyzozyme Inhibitor) a periplasmic protein produced by the Gram-negative organism Pseudomonas aeruginosa.
|
|
|
Term
|
Definition
Bacteria = - charge
Phospholipids and peptidoglycan = - charge
Defensins = + charge w/ hydrophobic residues ->
Destabalize microbial membranes creating pores and cell lysis
Defensins in secretions, host tissue, phagocytic cells |
|
|
Term
Interference with the activity of Defensins |
|
Definition
-Alteration of the electrostatic properties of the bacterial surface -Proteolysis of the defensins
-Production of external defensin-binding molecules
|
|
|
Term
Interference with the activity of IgA
|
|
Definition
-Proteases that specifically cleave IgA (Streptococcus pneumoniae)
- Production of IgA-binding proteins that compete with Fc receptors (Group A and B Streptococcus)
|
|
|
Term
Host innate immune defenses |
|
Definition
-Antimicrobial peptides (defensins) -Complement -Phagocytosis
|
|
|
Term
activated complement system response |
|
Definition
Membrane Attack Complex (MAC): Cell lysis
Opsonization of the pathogen to trigger phagocytosis
Initiates inflammatory response: Chemotaxis, increase of microvasculature permeability…
|
|
|
Term
Interference with the complement |
|
Definition
1-Inactivation of the complement by proteases
2-Attachment of soluble host complement regulators and production of complement inhibitors |
|
|
Term
Inactivation of the complement by proteases |
|
Definition
P. aeruginosa cleaves C3b, inhibiting the deposition of C3b onto the bacterial surface.
LPS variants that diminish C3b deposition.
|
|
|
Term
Host complement regulator |
|
Definition
CRASP (Complement Regulator Acquiring Surface Proteins): Factor H is a regulator of complement activation that protects self cells from complement activation. Factor H normally binds to host cell surfaces and inhibits the activation of the complement system. P. Aeruginosa binds to factor H.
|
|
|
Term
|
Definition
staphylococcal complement inhibitor (SCIN). SCIN is a protein secreted by S. aureus that specifically binds to and inhibits the activity of the C3 convertases on the bacterial surface.
|
|
|
Term
|
Definition
The capsule is a layer of polysaccharides outside the cell wall of bacteria. The capsule protects the bacteria from phagocytosis, activation of the complement system, desiccation. Prevents access of MAC to the outer membrane.
Capsule of Staphylococcus aureus and group B Streptococci inhibit the activation of the complement- SERUM RESISTANT-
|
|
|
Term
interference with complement - modification of lps |
|
Definition
prevents access of MAC to outer membrane
• SALMONELLA AND E. COLI SMOOTH STRAINS HAVE LONG O-ANTIGEN CHAINS • ROUGH MUTANTS ARE KILLED EASILY BY COMPLEMENT AND ARE "SERUM SENSITIVE"
|
|
|
Term
Avoid Phagocystosis by... |
|
Definition
1-Kill the phagocyte
2-Avoid phagocytosis
3-Survive phagocytosis
4-Utilize phagocytic cells to spread the infection
|
|
|
Term
How to kill the phagocyte to avoid phagocytosis
examples |
|
Definition
– Leukocidins attack the membrane of neutrophils and macrophages destroying them:
• Staphylococcus aureus • Streptococci • Pseudomonas aeruginosa
|
|
|
Term
2-Avoid phagocytosis
How to avoid recognition for phagocytosis
|
|
Definition
masking structures recognized by receptors
disguisins as host |
|
|
Term
2-Avoid phagocytosis
avoiding recognition by disguising as host examples |
|
Definition
-Streptococcal M-protein binds fibrinogen -Neisseria mimics host cell surface carbohydrates (look like blood group antigens).
|
|
|
Term
2-Avoid phagocytosis
avoiding recognition by masking structures recognized by phagocytic receptors |
|
Definition
– Avoid complement deposition – Avoid antibody deposition – Mask determinant recognized by phagocytic receptors
|
|
|
Term
2-Avoid phagocytosis
What happens when staphylococcal protein A and G coat the bacteria? |
|
Definition
Fc portion of antibodies bind to protein A and G: – No complement deposition – No binding to receptors on phagocytes
|
|
|
Term
2-Avoid phagocytosis
Examples of capsules |
|
Definition
– Streptococcus pneumoniae: The polysaccharide capsule of Streptococcus pneumoniae is the main virulence factor, which makes the bacterium resistant to phagocytosis. – Klebsiella pneumoniae – Hemophilus influenzae type B – E. coli - K-antigens – Yersinia pestis
|
|
|
Term
2-Avoid phagocytosis
Avoid recruitment of phagocytic cells |
|
Definition
-Blocking the activation of the complement system that normally releases chemotactic peptides (C5a and C3a).
-Production of virulence factors that inhibit chemotaxis.
|
|
|
Term
3-Survive Phagocytosis
Examples of pathogens that are ingested and resist microbicidal activites |
|
Definition
-Mycobacterium leprae Cell wall resistant to enzyme attack. - Staphylococcus aureus catalase positive destroy hydrogen peroxide (H2O2). -E. coli produce a superoxide dismutase that destroys superoxide (O2-).
|
|
|
Term
|
Definition
|
|
Term
Evasion from the Specific Immune Responses |
|
Definition
1. Toxicity against lymphocytes
2. Interference with the production of antibodies
3. Antigenic variations
4. Production of immunomodulatory proteins (Superantigens, cytokine mimicry…)
|
|
|
Term
Evasion from the Specific Immune Responses |
|
Definition
[image][image]
-Antibody deposition with the wrong orientation
Fc receptor binds instead of variable portion (upside down) |
|
|
Term
Evasion from the Specific Immune Responses-Inhibition of antibody production- |
|
Definition
Protein A: Binds to IgM on B cells
Proliferation and apoptosis of B cells
Depletion of a significant proportion of the B cell repertoire |
|
|
Term
Evasion from the Specific Immune Responses-Antigenic variation- |
|
Definition
Antigenic variation refers to the expression of a number of alternative forms of an antigen on the cell surface (such as lipoproteins, polysaccharides, type IV pili); this generates within a clonal population individual cells that are antigenically distinct, allowing bacterial pathogens to escape the host immune system.
|
|
|
Term
Evasion from the Specific Immune Responses-Antigenic variation-
spontaneous mutations vs phase variation |
|
Definition
Spontaneous mutations, which occur at a frequency of approximately 10-8 to 10-6 mutations
phase variation occurs at frequencies higher than 10-5 switches and always affects the same phenotype(s)
|
|
|
Term
Strain to strain variation in antigenic molecules |
|
Definition
molecules is common, antigenic variation refers to a single strain specifically changing a subset of its antigens, either to sustain an ongoing infection or re-infect hosts even though the first infection was successfully cleared.
|
|
|
Term
Evasion from the Specific Immune Responses-Antigenic variation-
1-Gene conversion |
|
Definition
Involves a recombination event between a silent copy of a gene and another copy that is expressed, and leads to the formation of a new chimeric gene. When several copies of the silent gene are present, numerous chimeric sequences can be theoretically generated, allowing to express various forms of an antigen.
|
|
|
Term
What is the causal agent of Lyme disease and what does it do? |
|
Definition
Borrelia burgdorferi
can generate variants expressing different antigenic forms of a surface lipoprotein
|
|
|
Term
What is the virulence componenet in gonorrhea |
|
Definition
Development of symptoms associated with gonorrhea is correlated with the ability of N. gonorrhoeae cells to attach and colonize mucous membranes via their pili, despite urinary flux.
Pil S can exchange portions of variable regions with PilE locus
|
|
|
Term
What is an On/Off switch? |
|
Definition
Variable gene expression based on differential DNA methylation. DNA methylation-dependent phase variation of the pap operon in E. coli .
|
|
|
Term
Evasion from the Specific Immune Responses -Antigenic variation-
involving on/off switch
|
|
Definition
2-Multiple but different copy of a molecule, each of which is under an independent on/off switch |
|
|
Term
How do you turn pap expression on and off |
|
Definition
LRP bound GATCdist region = activator/on
LRP bound GATCprox region = repressor of pB transcription/off
methylation at GATCdist decreased binding affinity = making it stay in off phase |
|
|
Term
Evasion from the Specific Immune Responses -Interfering with T cells-
|
|
Definition
1. Block T cell activation and proliferation
2. Expression of superantigens in host
3. Induction of T cell apoptosis |
|
|
Term
Example of T cell blocking
|
|
Definition
|
|
Term
How do superantigens interfere with T cells |
|
Definition
Expression of superantigens in the infected host also prevents development of a normal immune response. Antigen-specific T cells fail to proliferate in response to antigens that are presented normally by MHC class II due to a phenomenon called anergy.
|
|
|
Term
what does listeriolysin O do |
|
Definition
induces apoptotic response in T cells and macrophages |
|
|